Physician profile
Amanda Crum
NPI 1558593863
$1,451.77
in general payments reported to CMS, 2019-2025
11 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.87 · 2020: $175 · 2021: $317 · 2022: $202 · 2023: $202 · 2024: $301 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $421.12 | 2019-2025 | Precision7, Dailies Total1, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $271.03 | 2020-2025 | Acuvue |
| Abbvie INC. | $207.80 | 2022-2024 | Lumigan, Vuity |
| Sun Pharmaceutical Industries INC. | $172.81 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $111.26 | 2019-2023 | |
| Oyster Point Pharma, INC. | $85.64 | 2023-2024 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $75.54 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $34.40 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Coopervision INC. | $33.48 | 2021-2024 | Myday Contact Lens |
| Kala Pharmaceuticals, INC. | $22.30 | 2021 | |
| Shire North American Group INC | $16.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Crum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.